Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experience. - Sandeep KS; Appachu S; Diwaker RB; Vivek S; Simha VVS (Indian journal of cancer, 2025)